Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized double-blind multicenter trial of umbilical cord mesenchymal stem cell injection for knee osteoarthritis
CTR20252104Phase 2Active
- Sponsor
- Guangzhou Saliai Stem Cell Science and Technology Co., Ltd.
- Start
- Jul 2025
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of SALIAI-UC1 in knee osteoarthritis (OA), sponsored by Guangzhou Saliai Stem Cell Science and Technology Co., Ltd.. Started Jul 2025; status: active.
02
Drugs
SALIAI-UC1
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20252104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20252104.